Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal Cancer
Conditions: Rectal Cancer Interventions: Drug: liposomal irinotecan; Drug: Capecitabine; Radiation: Radiation threapy Sponsors: Hebei Medical University Fourth Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Hospitals | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Radiation Therapy | Neoadjuvant Therapy | Rectal Cancers | Research | Xeloda